Objective: The objective of this project was to describe the breakdown of project topics and geographic reach of Incentive Grant funded projects from 1994-2024 and summarize the number of patients or survey respondents reached.
Methods: All available reports and supporting documents for the Incentive Grants program were reviewed using the APhA Foundation internal database. Projects were assigned a geographical region using US Census Bureau Divisions, and categorized using focus areas from grant calls-for-proposals. Project impact was evaluated by summing the number of interventions reported in final reports.
Results: 784 projects were conducted and 551 had final reports available. Thirteen project focus areas were identified, with a majority of projects related to cardiovascular disease management (21.1%), pharmacy workflow/processes (14%), and immunizations (13.3%). Projects were conducted most frequently in the United States regions of South Atlantic (27.4%), East North Central (24.2%), and West North Central (14.9%). Of 398 projects with intervention-level data reported (2004-2024), 100,547 interventions were made (86,616 patients impacted and 13,931 survey respondents reached).
Conclusion: The findings of this study serve as a summary of community pharmacy-based research over time, indicating the APhA Foundation Incentive Grant program has likely had a positive influence on community pharmacy-based research as evidenced by number of funded projects, geographic scope, participant impact, and breadth of project focus.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.japh.2025.102323 | DOI Listing |
Genet Epidemiol
January 2025
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Large-scale gene-environment interaction (GxE) discovery efforts often involve analytical compromises for the sake of data harmonization and statistical power. Refinement of exposures, covariates, outcomes, and population subsets may be helpful to establish often-elusive replication and evaluate potential clinical utility. Here, we used additional datasets, an expanded set of statistical models, and interrogation of lipoprotein metabolism via nuclear magnetic resonance (NMR)-based lipoprotein subfractions to refine a previously discovered GxE modifying the relationship between physical activity (PA) and HDL-cholesterol (HDL-C).
View Article and Find Full Text PDFNat Med
January 2025
Food Is Medicine Institute, Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
The consumption of sugar-sweetened beverages (SSBs) is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). However, an updated and comprehensive assessment of the global burden attributable to SSBs remains scarce. Here we estimated SSB-attributable T2D and CVD burdens across 184 countries in 1990 and 2020 globally, regionally and nationally, incorporating data from the Global Dietary Database, jointly stratified by age, sex, educational attainment and urbanicity.
View Article and Find Full Text PDFJ Am Pharm Assoc (2003)
January 2025
Senior Manager, Communications and Program Engagement, APhA Foundation, Washington, DC.
Objective: The objective of this project was to describe the breakdown of project topics and geographic reach of Incentive Grant funded projects from 1994-2024 and summarize the number of patients or survey respondents reached.
Methods: All available reports and supporting documents for the Incentive Grants program were reviewed using the APhA Foundation internal database. Projects were assigned a geographical region using US Census Bureau Divisions, and categorized using focus areas from grant calls-for-proposals.
JACC Adv
January 2025
Veterans Affairs North Texas Healthcare System, Dallas, Texas, USA.
Background: Estimation of long-term risk for cardiovascular events using the SMART (Secondary Manifestations of Arterial Disease) risk score can be potentially valuable in devising risk mitigation strategies.
Objectives: The objective of this study was to apply the SMART risk score to compute the risk for major adverse cardiovascular events (MACE) in the U.S.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!